NCT01774890View on ClinicalTrials.gov

ST2, a Novel Biomarker for Cardiac Remodeling in Adults With Congenital Heart Disease

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2017

Conditions
Congenital Heart Disease
Trial Locations (1)

Unknown

Hadassah Medical Organizrtion, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT01774890 - ST2, a Novel Biomarker for Cardiac Remodeling in Adults With Congenital Heart Disease | Biotech Hunter | Biotech Hunter